logo

For the Inventor, By the Inventor

La Prairie, Canada

Francis Beaulieu

This inventor holds 16 USPTO granted patents and 2 EPO patents, primarily in HIV Integrase Inhibitors. Top assignees: Bristol-Myers Squibb Compnay, Taimed Biologics, Inc.. Active years: 2003-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francis Beaulieu. Retrieved from https://idiyas.com/inventor/francis-beaulieu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16

% Patents Active = 81.3


Average Co-Inventor Count = 7.3

ph-index = 5

Forward Citations = 64(Granted Patents)


Location History:

  • Quebec, CA (2012)
  • Laprairie, CA (2003 - 2014)

Company Filing History:

goldMedal15 out of 3,749 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal1 out of 5 
 
Taimed Biologics, Inc.
 patents

Years Active: 2003-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
HIV Integrase Inhibitors
Tyrosine Kinase Inhibitors
Topoisomerase Inhibitors
Bicyclic Heterocycles
Pyridoxine
Amino-Substituted Compounds
Tricyclic Compounds
Tumor Proliferation Inhibitors
Benzimidazole
C-2 Heterocycles
Cytotoxic Derivatives
Pharmaceutical Compositions
16 patents (USPTO):Explore Patents
1. 8742123 - HIV integrase inhibitors from pyridoxine (2014-06-03),
2. 8129398 - HIV integrase inhibitors (2012-03-06),
3. 8039458 - HIV integrase inhibitors (2011-10-18),
4. 7893055 - HIV integrase inhibitors (2011-02-22),
5. 7511037 - N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor (2009-03-31),
6. 7470696 - Tyrosine kinase inhibitors (2008-12-30),
7. 7312215 - Benzimidazole C-2 heterocycles as kinase inhibitors (2007-12-25),
8. 7189716 - Tyrosine kinase inhibitors (2007-03-13),
9. 7176196 - Bicyclic heterocycles as HIV integrase inhibitors (2007-02-13),
10. 7157447 - Bicyclic heterocycles as HIV integrase inhibitors (2007-01-02),
11. 7138377 - Topoisomerase inhibitors (2006-11-21),
12. 6960585 - Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same (2005-11-01),
13. 6933294 - Thiophene-based tricyclic compounds and pharmaceutical compositions comprising same (2005-08-23),
14. 6855698 - Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles (2005-02-15),
15. 6677450 - Topoisomerase inhibitors (2004-01-13),

Title: The Inventor Francis Beaulieu: Pioneering Innovations in La Prairie, CA

Introduction: Francis Beaulieu is a renowned inventor based in La Prairie, CA, known for his groundbreaking contributions to the field of technology and engineering.

Latest Patents: Francis Beaulieu holds several patents in various industries, including telecommunications, renewable energy, and consumer electronics.

Career Highlights: With a career spanning over two decades, Francis Beaulieu has worked with leading tech companies to develop cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Francis Beaulieu has collaborated with top researchers, engineers, and designers to bring his ideas to life, resulting in successful products that have had a significant impact on the market.

Conclusion: Francis Beaulieu continues to be a driving force in the world of innovation, constantly pushing the boundaries of what is possible and inspiring the next generation of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…